Automation In Biopharma Industry Market Outlook 2025-2034: Key Trends, Growth Drivers, and Market Share

How Are the key drivers contributing to the expansion of the automation in biopharma industry market?
The escalating use of robots in the creation of pharmaceutical products is set to accelerate the expansion of the automation in biopharma industry market. Advanced automated systems, or robots, are often employed for various tasks in pharmaceutical manufacturing, such as secondary packaging, intralogistics, laboratory automation, pick and place, automation of pharmacy procedures, and personalized medicine. These tasks result in heightened productivity, superior precision, diminished contamination risk, and improved safety for workers. The International Federation of Robotics, a non-profit professional organization based in Germany, disclosed that in September 2024, industrial robot installations in Europe's manufacturing industry surged by 9%, reaching a historic high of 92,393 units. Out of these, 73,534 units or 80% were installed within the European Union, indicating a 2% increase from the previous year. Consequently, the growing use of robots in pharmaceutical manufacturing is set to propel the expansion of the automation in biopharma industry market.

Get Your Automation In Biopharma Industry Market Report Here:
https://www.thebusinessresearchcompany.com/report/automation-in-biopharma-industry-global-market-report

What growth opportunities are expected to drive the automation in biopharma industry market's CAGR through 2034?
The biopharma industry's automation market size has seen robust growth recently. The market is projected to expand from $2.08 billion in 2024 to $2.2 billion in 2025, witnessing a compound annual growth rate (CAGR) of 5.9%. This growth in the historic period is due to factors such as the increasing complexity of biopharmaceutical processes, the need for enhanced process efficiency, growth in the development and manufacturing of biologics, the demand for quality assurance and control, and pressure to shorten time-to-market.

The biopharma industry's automation market is anticipated to experience robust expansion in the upcoming years, with its size projected to escalate to $2.92 billion by 2029, at a compound annual growth rate (CAGR) of 7.4%. The forecasted growth is primarily due to improvements in data accuracy and record-keeping, the emergence of personalized medicine and modular, flexible bioprocessing facilities, progression of automation platforms, increased need for biosimilars, and the uptake of smart sensors and internet of things (IoT). Further, the forecast period is set to witness trends such as the development in robotics and automation technologies, progress in single-use technologies, integration of artificial intelligence into bioprocessing, enhancements in process analytical technologies (PAT), collaborations between biopharma and technology firms, and a focus on sustainability in biopharma automation.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12704&type=smp

What are the emerging trends shaping the future of the automation in biopharma industry market?
Innovations in technology are increasingly influencing the automation in biopharma industry market, creating a major trend. To secure their market position, prominent companies in this sector are focused on producing technologically advanced products. For example, PerkinElmer Inc., a US company known for its scientific technologies and solutions, debuted the Cellaca PLX Image Cytometry System in September 2022. This groundbreaking system automates cell analysis and makes cell and gene therapy research and production more streamlined. The Cellaca PLX platform enables critical quality attributes like identity, quantity, and quality of cell samples to be evaluated through an automated process. The system integrates image cytometer hardware, software, pre-validated consumables, and traceable data reporting to ease calibration and training needs.

Which growth-oriented segments of the automation in biopharma industry market are leading the industry's development?
The automation in biopharma industry market covered in this report is segmented -

1) By Technology: Automation Technology, Digitization Technology
2) By Component: Automation Hardware, Automation Software, Services Project Phase, Services Operation Phase
3) By Application: Clinical Phase, Drug Discovery Phase, Production Phase

Subsegments:
1) By Automation Technology: Process Automation, Laboratory Automation, Robotics And Artificial Intelligence, Control Systems, Programmable Logic Controllers (PLCs)
2) By Digitization Technology: Data Analytics And Visualization, Electronic Lab Notebooks (ELN), Cloud Computing, Internet Of Things (IoT) In Pharma, Digital Twin Technology

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12704

What regions are leading the charge in the automation in biopharma industry market?
North America was the largest region in the automation in biopharma industry market in 2024. The regions covered in the automation in biopharma industry market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What companies are at the forefront of innovation in the automation in biopharma industry market?
Major companies operating in the automation in biopharma industry market include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, ABB Ltd, Siemens Healthineers AG, Emerson Electric Co., Becton Dickinson and Company (BD), Corning Incorporated, Rockwell Automation Inc., Agilent Technologies Inc., PerkinElmer Inc., Sartorius AG, bioMérieux SA, Mettler-Toledo International Inc., Beckman Coulter Inc., Waters Corporation, Pall Corporation, Bruker Corporation, Qiagen N.V., Eppendorf AG, Tecan Group Ltd., Promega Corporation, Brooks Automation Inc., Omron Automation, Hamilton Company, Integra Biosciences AG, Gilson Inc., Analytik Jena AG, BioTek Instruments Inc.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12704&type=smp

What Is Covered In The Automation In Biopharma Industry Global Market Report?

• Market Size Forecast: Examine the automation in biopharma industry market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the automation in biopharma industry market for a structured understanding.
• Key Players Overview: Analyze major players in the automation in biopharma industry market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the automation in biopharma industry market.
• Segment Contributions: Evaluate how different segments drive overall growth in the automation in biopharma industry market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the automation in biopharma industry market.
• Industry Challenges: Identify potential risks and obstacles affecting the automation in biopharma industry market.
• Competitive Landscape: Review strategic developments in the automation in biopharma industry market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.